[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mural Oncology Plc (MURA)

Mural Oncology Plc (MURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mural Oncology Plc 10 Earlsfort Terrace Dublin L2 D02 T380 IRL

www.muraloncology.com Employees: 116 P: 353-1905-8020

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Mural Oncology plc is a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein engineering to develop novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Mural Oncology plc is based in DUBLIN, Ireland.

Key Statistics

Overview:

Market Capitalization, $K 35,382
Enterprise Value, $K -80,078
Shares Outstanding, K 17,344
Float, K 16,962
% Float 97.80%
Short Interest, K 433
Short Float 0.00%
Days to Cover 1.43
Short Volume Ratio 0.33
% of Insider Shareholders 2.20%
% of Institutional Shareholders 80.21%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -128,510 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,710 K
EBIT, $ -123,040 K
EBITDA, $ -119,530 K

Growth:

1-Year Return -49.13%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 11/06/25
Next Earnings Date 03/10/26
Earnings Per Share ttm -5.92
EPS Growth vs. Prev Qtr 88.14%
EPS Growth vs. Prev Year 88.77%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MURA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -112.17%
Return-on-Assets % -89.37%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.64
Book Value/Share 3.18
Interest Coverage -3.66
60-Month Beta 2.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.